Brief: Next Science Receives FDA Warning Letter
25/02/2025 01:29
Feb 25 (Reuters) - Next Science Ltd NXS.AX :
* NEXT SCIENCE RECEIVES FDA WARNING LETTER
* WARNING LETTER RELATES TO FDA'S INSPECTION OF CO'S
JACKSONVILLE,
FLORIDA FACILITY DURING AUG & SEPT 2024
* UNDERTAKEN CORRECTIVE ACTIONS TO ADDRESS MATTERS RAISED BY
FDA,
INCLUDING REVISING PRODUCT DESCRIPTIONS ON CO'S WEBSITE
Further company coverage: NXS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Next Science
See all newsBrief: ASX Says Next Science Limited Will Be Removed From Official List
Brief: Next Science Says CEO & Managing Director I.V. Hall, and CFO Marc Zimmerman Resigned
Brief: Next Science Releases Quarterly Activity Report
Australia's Next Science surges on sale of assets for $50 million
Brief: Next Science To Sell Majority Of Assets